EUVIMEDEUVIMED entdecken
Crossref

Adipocyte Mesenchymal Stem Cells Derived Exosomes Improve Bleomycin‐Induced Lung Fibrosis in Rat

Atefeh Ashtari, Maryam Radan, Dian Dayer, Maryam Zohour Soleimani iD, Vahid Bayati, Fereshteh Nejaddehbashi

Artificial Organs · 2025

DOI: 10.1111/aor.70052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Atefeh Ashtari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Hauptthemen laut MEDLINE: Exosomes, Mesenchymal Stem Cells, Pulmonary Fibrosis, Adipocytes. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Ahvaz Jundishapur University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible lung disease with limited treatment options. Although extracellular vesicles (EVs), such as exosomes, have shown therapeutic potential, their effectiveness and the best method of delivery are still under investigation. This study explored the therapeutic impact of exosomes derived from adipose‐derived mesenchymal stem cells (ADMSCs‐Exo) in a rat model of bleomycin‐induced pulmonary fibrosis.

Methods

Thirty Wistar rats were randomly divided into six groups: (1) Healthy control (Co), (2) Fibrosis control (Co/F), (3 and 4) Exosome inhalation groups treated with 250 or 500 μg/kg doses, and (5 and 6) Exosome injection groups receiving the same doses. Treatment effects were evaluated through lung tissue histopathology and analysis of key inflammatory biomarkers.

Results

The inhalation of ADMSCs‐Exo at both doses significantly reduced levels of C‐reactive protein (CRP), fibrinogen, pro‐inflammatory cytokines, and histopathological signs of lung fibrosis compared to the fibrosis control group ( p < 0.05). Notably, the inhalation route showed better therapeutic outcomes than systemic injection.

Conclusion

The results suggest that inhalation delivery of ADMSCs‐derived exosomes may provide a more effective and targeted strategy for treating pulmonary fibrosis compared to systemic administration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesMesenchymal Stem CellsPulmonary FibrosisAdipocytesAnimalsBleomycinRats, WistarRatsDisease Models, AnimalMaleLungMesenchymal Stem Cell TransplantationAdministration, Inhalation

Stichwörter der Autor:innen

exosomemesenchymal stem cellspulmonary fibrosisstem cell

Substanzen

Bleomycin

Autor:innen und Institutionen

  • Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Department of Anatomical Sciences, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

ORCID-Profile: Maryam Zohour Soleimani

Förderung

  • Ahvaz Jundishapur University of Medical Sciences

Zitieren

APA

Ashtari, A., Radan, M., Dayer, D., Soleimani, M. Z., Bayati, V., & Nejaddehbashi, F. (2025). Adipocyte Mesenchymal Stem Cells Derived Exosomes Improve Bleomycin‐Induced Lung Fibrosis in Rat. Artificial Organs. https://doi.org/10.1111/aor.70052

Vancouver

Ashtari A, Radan M, Dayer D, Soleimani MZ, Bayati V, Nejaddehbashi F. Adipocyte Mesenchymal Stem Cells Derived Exosomes Improve Bleomycin‐Induced Lung Fibrosis in Rat. Artificial Organs. 2025. doi:10.1111/aor.70052

BibTeX
@article{Ashtari2025,
  author = {Ashtari, Atefeh and Radan, Maryam and Dayer, Dian and Soleimani, Maryam Zohour and Bayati, Vahid and Nejaddehbashi, Fereshteh},
  title = {Adipocyte Mesenchymal Stem Cells Derived Exosomes Improve Bleomycin‐Induced Lung Fibrosis in Rat},
  journal = {Artificial Organs},
  year = {2025},
  doi = {10.1111/aor.70052}
}
Kostenlos starten →